Structure–Activity Relationship of N-Cyclopropylmethyl-7α-[para-(arylcarboxamido)phenyl]-6,14-endoethano-tetrahydronorthebaines as Potent and Selective Kappa Opioid Receptor Agonists
Authors:
- 28 July 2025
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 68 (15) , 15889-15909
Abstract
Research on KOR agonists with reduced central nervous system side effects represents a significant area in analgesic studies. Herein, a structure-activity relationship analysis was performed for a series of N-cyclopropylmethyl-7α-[para-(arylcarboxamido)phenyl]-6,14-endoethano-tetrahydronorthebaines. Several highly selective and potent KOR agonists have been identified. Notably, compound 5i exhibited a subpicomolar binding affinity for KOR and exceptional subtype selectivity over MOR and DOR, consistent with its in vitro functional activities. It was identified as a G protein-biased KOR agonist, and its molecular interactions with KOR were elucidated. Additionally, this compound exhibited potent, dose-dependent, long-lasting, and KOR-mediated antinociceptive activity in both hot plate and abdominal constriction assays. It did not display any noticeable aversion or sedation in rodent models. These pharmacological characteristics suggest that compound 5i is a promising candidate for further studies.Keywords
Funding Information
- Natural Science Foundation of Shanghai Municipality (23ZR1474900, 24ZR1413700)
- Ministry of Science and Technology of the People's Republic of China (2021ZD0202900, 2021ZD0203500)
- Taishan Scholar Project of Shandong Province
- National Natural Science Foundation of China (82030112, 82073765, 82273853)
- Key Technology Research and Development Program of Shandong Province (2024CXPT029)
- Science and Technology Innovation and development Plan in Yantai City (2024JCYJ045)
- Shandong Laboratory Program (SYS202205)
This publication has 58 references indexed in Scilit:
- Difelikefalin: First ApprovalDrugs, 2021
- Preclinical Studies on Nalfurafine (TRK-820), a Clinically Used KOR Agonist2021
- Quantification of observable behaviors induced by typical and atypical kappa-opioid receptor agonists in male rhesus monkeysPsychopharmacology, 2020
- Synthesis of new opioid derivatives with a propellane skeleton and their pharmacologies: Part 5, novel pentacyclic propellane derivatives with a 6-amide side chainBioorganic & Medicinal Chemistry, 2015
- Synthesis and evaluation of κ-opioid receptor agonistic activity and antinociceptive effect of novel morphine analogues, 7α-phenyl-6α,14α-endo-etheno-tetrahydrothebaine with substituted o-, m- and p-amino groupMedicinal Chemistry Research, 2010
- Subjective, psychomotor, and physiological effects of cumulative doses of mixed-action opioids in healthy volunteersPsychopharmacology, 2001
- Identification of the amino acid residues involved in selective agonist binding in the first extracellular loop of the δ‐ and μ‐opioid receptorsFEBS Letters, 1995
- DAMGO, a μ‐opioid receptor selective agonist, distinguishes between μ‐ and δ‐opioid receptors around their first extracellular loopsFEBS Letters, 1995
- κ-Opioid receptors and analgesiaTrends in Pharmacological Sciences, 1990
- Bivalent ligands and the message-address concept in the design of selective opioid receptor antagonistsTrends in Pharmacological Sciences, 1989